NO REAL SUBSTANTIVE TRIALS
What UK law says The short version: none of these are licensed medicines in the UK, and supplying any of them for human use without a marketing authorisation is unlawful under the Human Medicines Regulations 2012
Accordingly, copper may preferentially accumulate in this tissue, potentially facilitating activation of the copper-induced cell death pathway
In the era of the cancer nanomedicine, many formulations, examples such as Abraxane, NanoTherm, and Combidexcomprising both organic and inorganic nanoparticleshave received clinical approval or are currently in clinical trials for solid tumors, but very few for glioblastoma (96, Table 5 )
Leytus SP, Loeb KR, Hagen FS, Kurachi K, Davie EW